DMT

If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you. The Toronto-based company is studying derivatives of psilocybin and DMT and plans to file an investigational new drug application with the FDA during this quarter, CEO Doug...

This article by Lester Black was originally published on Microdose and appears here with permission. DMT earned its “businessman’s lunch” nickname in the 1980s thanks to the molecule’s paradoxically strong yet short-acting psychedelic effects. With a high that can...

This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming...

This article was originally published on Cannabis.net and appears here with permission. It’s 2022, and we’re decades away from the 60’s but psychedelics sure are having another hey day. The use of psilocybin as well as other hallucinogenic psychedelic drugs...

This article was originally published on Psychedelic Spotlight and appears here with permission. In this opinion piece, Psychedelic Investor James Hallifax leans heavy on sarcasm to point out why it's problematic that a patent has been granted for an "invention" that is currently...

This article was originally published on Psychedelic Spotlight and appears here with permission. The psychedelic facilitators tell us open-minded participants, who have a willingness to dive deep into their inner world generally have the most success at the Tandava Retreat wellness center in...

Psychedelics company Cybin Inc. (NEO: CYBN) (AMEX: CYBN) announced that the U.S. Patent and Trademark Office has granted U.S. patent 11,242,318 to the company’s investigational deuterated dimethyltryptamine (“DMT”) compound CYB004. The allowed claims include a range of...

Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics committee for a Phase 1 clinical trial evaluating the pharmacokinetics, pharmacodynamics and safety profile of the psychedelic compound DMT. DMT is known as the active...

This article was originally published on Microdose and appears here with permission. A brief history of DMT N,N-Dimethyltryptamine, known as DMT or the “spirit molecule”, is a compound found throughout nature that has profound effects on human consciousness. The importance of...

This article was originally published on Reality Sandwich, and appears here with permission. Do We Have Souls or Are We One With the Universe? Many religious traditions believe that humans possess an immaterial soul. According to such traditions, the soul is the non-physical essence of who we are...

PharmaDrug Inc. (CSE: BUZZ) (Pink: LMLLF) announced an FDA-granted Orphan Drug Designation to its wholly owned subsidiary Sairiyo Therapeutics Inc., for the use of DMT in organ transplantations. When patients undergo an organ transplant, there's a high risk of ischemia-reperfusion injury, a...

A bill to decriminalize psychedelic substances in California is quickly moving up the legislative ladder. Introduced in February by Sen. Scott Wiener, SB 519 would remove penalties for the possession, personal use and social sharing of certain natural and synthetic psychoactive drugs...

Entheon Biomedical Corp. (OTC: ENTBF) a company dedicated to the application of the psychedelic DMT in the treatment of addiction, announced the launch of a psychedelics genetic test kit, through its wholly-owned subsidiary, HaluGen Life Sciences Inc. The test will serve as a pre-screening...

This article by Lauren Sasser was originally published on Reality Sandwich, and appears here with permission. DMT Milking? People are abducting toads for their psychedelic milk? That’s right. DMT milking produces some of the most powerful hallucinations. Some claim it’s...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. United Kingdom-based startup Beckley Psytech is gearing up for a Phase 1 clinical trial investigating a synthetic version of 5-MeO-DMT. The trial is looking at...